IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma.

Med Oncol

Department of Translational Medicine (DIMET), Department of Radiation Oncology, "Maggiore della Carità" University Hospital, University of Eastern Piedmont, 28100, Novara, Italy.

Published: November 2023

The aim of this editorial is to focus on the urgent need to improve clinical outcomes in patients with bulky primary anal canal carcinoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645633PMC
http://dx.doi.org/10.1007/s12032-023-02224-1DOI Listing

Publication Analysis

Top Keywords

anal canal
8
canal carcinoma
8
iap inhibitor
4
inhibitor chemoradiotherapy
4
chemoradiotherapy treatment
4
treatment bulky
4
bulky anal
4
carcinoma aim
4
aim editorial
4
editorial focus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!